We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

212 hedge funds and large institutions have $2B invested in Ironwood Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 78 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

524% more call options, than puts

Call options by funds: $8.35M | Put options by funds: $1.34M

3.89% less ownership

Funds ownership: 108.92% → 105.03% (-3.9%)

7% less funds holding

Funds holding: 227 → 212 (-15)

10% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 78

14% less capital invested

Capital invested by funds: $2.31B → $2B (-$314M)

30% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 43

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
212
Holders Change
-15
Holders Change %
-6.61%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
30
Increased
70
Reduced
78
Closed
43
Calls
$8.35M
Puts
$1.34M
Net Calls
+$7.01M
Net Calls Change
-$3.26M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$23.3M
2
Norges Bank
Norges Bank
Norway
+$15.2M
3
ECM
ExodusPoint Capital Management
New York
+$6.99M
4
RA
Royce & Associates
New York
+$5.9M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.76M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$30.7M
2
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$22.2M
3
PI
Putnam Investments
Massachusetts
-$17.3M
4
UBS AM
UBS AM
Illinois
-$12.1M
5
BCM
Brown Capital Management
Maryland
-$9.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
TMAM
151
Tokio Marine Asset Management
Japan
$258K +$44.2K +3,600 +19%
BAM
152
Blueshift Asset Management
New Jersey
$255K -$39.6K -3,229 -13%
RJA
153
Raymond James & Associates
Florida
$253K +$266K +21,699 New
II
154
Inspire Investing
Idaho
$245K +$44.1K +3,592 +21%
PHK
155
Point72 Hong Kong
Hong Kong
$245K +$217K +17,708 +533%
OSAM
156
O'Shaughnessy Asset Management
Connecticut
$231K +$26.9K +2,195 +12%
Group One Trading
157
Group One Trading
Illinois
$230K -$7.2K -587 -3%
Zurich Cantonal Bank
158
Zurich Cantonal Bank
Switzerland
$226K – – –
CCIA
159
Campbell & Co Investment Adviser
Maryland
$219K -$58.9K -4,800 -20%
ETM
160
Euclidean Technologies Management
Washington
$215K – – –
SEC
161
Seven Eight Capital
New York
$214K -$595K -48,509 -73%
WCM
162
Wedge Capital Management
North Carolina
$214K +$39K +3,182 +21%
PFS
163
Prospera Financial Services
Texas
$191K +$201K +16,375 New
Acadian Asset Management
164
Acadian Asset Management
Massachusetts
$183K -$3.55M -289,128 -95%
EFM
165
E Fund Management
China
$182K +$18.1K +1,472 +10%
PA
166
Profund Advisors
Maryland
$178K +$8.13K +663 +5%
MS
167
Maven Securities
Jersey
$175K – – –
HWAM
168
Hennion & Walsh Asset Management
New Jersey
$175K +$184K +15,035 New
SWM
169
Spire Wealth Management
Virginia
$175K +$185K +15,051 New
First Manhattan
170
First Manhattan
New York
$174K – – –
Osaic Holdings
171
Osaic Holdings
Arizona
$169K +$77.2K +6,289 +77%
SOW
172
State of Wyoming
Wyoming
$158K +$134K +10,919 +423%
AIM
173
Aigen Investment Management
New York
$157K +$165K +13,458 New
US Bancorp
174
US Bancorp
Minnesota
$151K +$16.5K +1,344 +12%
RJFSA
175
Raymond James Financial Services Advisors
Florida
$139K +$5.12K +417 +4%
5 6
7
8 9

IRWD Hedge Fund Activity: Q4 2021 in Review

212 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2021, worth a combined $2B — down 14% from $2.31B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of IRWD and 30 opened new positions — a net loss of 13 holders — while 78 trimmed existing stakes and 70 added.

The largest buyer was BlackRock, adding an estimated $23.3M. The largest seller was Camber Capital Management, cutting an estimated $30.7M.

  • 212 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2021, down from 227 in Q3 2021.
  • Funds reported $2B of Ironwood Pharmaceuticals stock for Q4 2021, down 14% quarter-over-quarter.
  • 30 funds opened new Ironwood Pharmaceuticals positions in Q4 2021 and 43 closed out, a net change of -13 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2021 was BlackRock, an estimated $23.3M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2021 was Camber Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q4 2021.